Bioarchitech Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $1.2M

  • Investors
  • 2

Bioarchitech General Information

Description

Operator of a biotechnology company intended to improve cancer therapy. The company engineers antibodies and other proteins, encoding them within the genome of an oncolytic virus that releases potent immunotherapy molecules into the surrounding tumor microenvironment, enabling physicians to orchestrate the destruction of tumor cells by the patient's own immune system.

Contact Information

Website
www.bioarchitech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Wood Centre for Innovation, Quarry Road
  • Headington
  • Oxford OX3 8SB
  • England, United Kingdom
+44 01865
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Wood Centre for Innovation, Quarry Road
  • Headington
  • Oxford OX3 8SB
  • England, United Kingdom
+44 01865

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioarchitech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Angel (individual) 01-Feb-2022 $1.2M Completed Generating Revenue
7. Angel (individual) 05-May-2021 Completed Generating Revenue
6. Angel (individual) 03-Apr-2019 Completed Generating Revenue
5. Angel (individual) 20-Oct-2017 Completed Generating Revenue
4. Grant 01-Dec-2016 Completed Generating Revenue
3. Early Stage VC 17-Mar-2016 Completed Generating Revenue
2. Grant 01-Oct-2015 $298K $155K Completed Generating Revenue
1. Early Stage VC 13-Aug-2015 $155K $155K Completed Generating Revenue
To view Bioarchitech’s complete valuation and funding history, request access »

Bioarchitech Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 50,000 $0.001355 $1.36 $1.36 1x $1.36 3.79%
Ordinary 165,750 $0.001355 $0.81 $0.81 1x $0.81 12.57%
To view Bioarchitech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Bioarchitech Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Bioarchitech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202500839-D0 Oncolytic rna composition Pending 21-Jan-2025
GB-202418719-D0 Cd47 antibody Pending 19-Dec-2024
GB-201621665-D0 Chimeric oncolytic virus Inactive 20-Dec-2016
GB-201522317-D0 Chimeric oncolytic virus Inactive 17-Dec-2015

Bioarchitech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bioarchitech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Government
Oxford Technology Management Venture Capital Minority
To view Bioarchitech’s complete investors history, request access »

Ready to get started?

Request a free trial

Bioarchitech FAQs

  • When was Bioarchitech founded?

    Bioarchitech was founded in 2014.

  • Where is Bioarchitech headquartered?

    Bioarchitech is headquartered in Oxford, United Kingdom.

  • What is the size of Bioarchitech?

    Bioarchitech has 7 total employees.

  • What industry is Bioarchitech in?

    Bioarchitech’s primary industry is Biotechnology.

  • Is Bioarchitech a private or public company?

    Bioarchitech is a Private company.

  • What is the current valuation of Bioarchitech?

    The current valuation of Bioarchitech is .

  • What is Bioarchitech’s current revenue?

    The current revenue for Bioarchitech is .

  • How much funding has Bioarchitech raised over time?

    Bioarchitech has raised $3.43M.

  • Who are Bioarchitech’s investors?

    Innovate UK and Oxford Technology Management have invested in Bioarchitech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »